University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 7 of 15
Project COPE (Coping Options for Parent Empowerment)
NCT04715906
SmartManage Stress Management for HIV+ Cancer Survivors
NCT04544917
Sleep & Postoperative Delirium in Hispanic/ Latino Patients After Cardiothoracic Surgery
NCT04786899
Dexamethasone for Post Uterine Artery Embolization Pain
NCT04655144
Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain
NCT04578574
Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification
NCT04069104
Personalized Assessment of Client Experiences
NCT04369924
Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma
NCT04189952
Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis
NCT04505410
Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care
NCT04316715
Cross Sectional CFAR HIV/COVID-19 Study
NCT04514016
A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections
NCT04439799
Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction.
NCT04396795
CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment
NCT04431856
Mindfulness Training for Seniors
NCT04378803
Restorative Eye Treatment and INhance in Upper Eyelid Blepharoplasty Surgery
NCT05007288
Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology
NCT04440098
Testopel ® vs. Generic Testosterone Pellets.
NCT04523480
Preventing Chronic Disease: ActuaYa
NCT04088552
Noise Exposure and Near-Infrared Light
NCT03834714
Wound Dressings for Hidradenitis Suppurativa
NCT04194541
Stress-induced Scratching in Healthy and AD
NCT04174651
High-Speed Yoga and Executive Function
NCT04215900
Orthostatic, Respiratory, Balance-Intervention
NCT04210063
Diet Intervention for Crohn's Disease Patient
NCT04213729
Crural Dissection in Sleeve Gastrectomy
NCT04168060
3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma
NCT03825913
Patient Performance and Acceptance of Virtual Reality Visual Field Devices
NCT04786886
Remote Microphone (RM) - A Comparative Study
NCT04147611
Exercise and Nutrition on Obese Microbiome
NCT04138303
My Health Day by Day (Mi Salud Dia a Dia)
NCT04545021
The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men
NCT03839212
Mindfulness Based Smoking Cessation Among Cancer Survivors
NCT04038255
Semaglutide vs Dulaglutide on Epicardial Adipose Tissue
NCT04200625
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
NCT03999411
Piano Training, Caregivers, and Parkinson's Disease
NCT03922672
Heart Inflammation and Mental Stress Study
NCT03695146
High Speed Circuit Training and Cognition
NCT04022707
MCRF Clinical Pilot Study
NCT03991585
Topical Acetaminophen for Itch Relief: a Proof of Concept Study in Healthy Subjects
NCT03997851
Association Between Cancer and Sarcoidosis
NCT03844698
Mohs Surgery: Patient Satisfaction & Quality of Life (QOL)
NCT04936906
The Effect of Lumify™ Eyedrops on Eyelid Position
NCT03782701
90 DAYS: An Entertainment Education Intervention to Evaluate a Short Film About HIV Status Disclosure
NCT03898063
Low Intensity Shockwaves Therapy for the Treatment of Erectile Dysfunction. 12- Month Follow-Up
NCT03670628
Hispanic Men Building Respect Education and Safety/ HoMBRES Manteniendo Respeto, Educacion y Seguridad.
NCT03730987
Fecal Microbial Transplant (FMT) for Sjogrens Syndrome
NCT03926286
Focused Cardiac Ultrasound
NCT03887286
Culturally Modified Family Based Therapy for Haitian Youth in South Florida
NCT03876171
Cognition and Neuroplasticity Sedentary Adults After 8 Weeks of Aerobic Exercise
NCT03804528
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Miami pipeline card: 721 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.